Janeen Doyle
Fortune : 1 M $ au 31/07/2026
Fortune : 1 M $ au 31/07/2026
Ms. Janeen Doyle is a Chief Corporate & Business Development Officer at Janux Therapeutics, Inc. Ms. Doyle was previously employed as a Senior VP-Strategy & Business Development by Bristol Myers Squibb Co. and a Senior VP-Strategy & Business Development by Celgene Corp.
She received her undergraduate degree from Moravian College and an MBA from the University of Scranton.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/06/2026 | 75 941 ( 0,13% ) | 1 M $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Corporate Officer/Principal | 15/05/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| CELGENE | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Moravian College
Moravian College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Scranton
University of Scranton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janux Therapeutics, Inc.
Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national